Trial intelligence / Profile preview

Gingivitis and Plaque Effects of Stannous Fluoride Dentifrices

NCT06140784Completed

Sponsor
Procter & Gamble
Start
Sep 2023
Primary completion
Dec 2023
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised, double-blind trial of stannous fluoride in gingivitis (4 arms), sponsored by Procter & Gamble. Primary endpoint: Löe-Silness Gingivitis Evaluation at 3 Months. Started Sep 2023; status: completed.

02

Drugs

stannous fluoride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT06140784.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06140784.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call